Cargando…

The Origins and Risk Factors for Serotype-2 Vaccine-Derived Poliovirus Emergences in Africa During 2016–2019

Serotype 2 oral poliovirus vaccine (OPV2) can revert to regain wild-type neurovirulence and spread to cause emergences of vaccine-derived poliovirus (VDPV2). After its global withdrawal from routine immunization in 2016, outbreak response use has created a cycle of VDPV2 emergences that threaten era...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gray, Elizabeth J, Cooper, Laura V, Bandyopadhyay, Ananda S, Blake, Isobel M, Grassly, Nicholas C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304761/ https://www.ncbi.nlm.nih.gov/pubmed/36630295 http://dx.doi.org/10.1093/infdis/jiad004

Ejemplares similares

Time Taken to Detect and Respond to Polio Outbreaks in Africa and the Potential Impact of Direct Molecular Detection and Nanopore Sequencing
por: Shaw, Alexander G, et al.
Publicado: (2021)

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa
por: Cooper, Laura V, et al.
Publicado: (2022)

Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic()
por: Molodecky, Natalia A, et al.
Publicado: (2023)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Characterizing Environmental Surveillance Sites in Nigeria and Their Sensitivity to Detect Poliovirus and Other Enteroviruses
por: Hamisu, Abdullahi Walla, et al.
Publicado: (2020)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial
por: John, Jacob, et al.
Publicado: (2017)

Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018–2019
por: Zhao, Hehe, et al.
Publicado: (2021)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Influence of Enteric Infections on Response to Oral Poliovirus Vaccine: A Systematic Review and Meta-analysis
por: Parker, Edward P. K., et al.
Publicado: (2014)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

Sensitivity of the acute flaccid paralysis surveillance system for poliovirus in South Africa, 2016–2019
por: Howard, Wayne, et al.
Publicado: (2021)

Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

FUT2 Secretor Status Is Not Associated With Oral Poliovirus Vaccine Immunogenicity in South Indian Infants
por: Parker, Edward P K, et al.
Publicado: (2019)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis
por: Molodecky, Natalie A., et al.
Publicado: (2017)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
por: Shirreff, George, et al.
Publicado: (2017)

Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge
por: Hird, Thomas R., et al.
Publicado: (2012)

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

Quantity of Vaccine Poliovirus Shed Determines the Titer of the Serum Neutralizing Antibody Response in Indian Children Who Received Oral Vaccine
por: Giri, Sidhartha, et al.
Publicado: (2018)

Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates
por: Williams, Lucy R, et al.
Publicado: (2021)

Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study
por: O’Reilly, Kathleen M., et al.
Publicado: (2018)

Influence of Nonpolio Enteroviruses and the Bacterial Gut Microbiota on Oral Poliovirus Vaccine Response: A Study from South India
por: Praharaj, Ira, et al.
Publicado: (2019)

Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
por: Wassilak, Steven, et al.
Publicado: (2011)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis
por: Grassly, Nicholas C.
Publicado: (2014)

A Statistical Model of the International Spread of Wild Poliovirus in Africa Used to Predict and Prevent Outbreaks
por: O'Reilly, Kathleen M., et al.
Publicado: (2011)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023
por: Davlantes, Elizabeth, et al.
Publicado: (2023)

The re-emergence of wild poliovirus type 1 in Africa and the role of environmental surveillance in interrupting poliovirus transmission
por: Gwinji, Phanuel Tawanda, et al.
Publicado: (2022)

Contribution of Contact Sampling in Increasing Sensitivity of Poliovirus Detection During A Polio Outbreak—Somalia, 2013
por: Moturi, Edna, et al.
Publicado: (2016)

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Incidence and Predictors of Community-Acquired Pneumonia in Patients With Hematological Cancers Between 2016 and 2019( )
por: Certan, Maria, et al.
Publicado: (2022)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
por: Grassly, Nicholas C., et al.
Publicado: (2018)

Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model
por: Collett, Marc S., et al.
Publicado: (2017)

Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
por: Faye, Martin, et al.
Publicado: (2022)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017
por: Jorba, Jaume, et al.
Publicado: (2017)

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
por: Thompson, Kimberly M., et al.
Publicado: (2017)

Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa
por: Kogan, Nicole E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ejutbeb087vhbjn3d4vlp5gkk